E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 6.36% -12.82% -15.00% -36.27% -22.98%
Total Other Revenue -- -- -- -- --
Total Revenue 6.36% -12.82% -15.00% -36.27% -22.98%
Cost of Revenue -1.61% -21.60% -26.72% -90.73% 24.39%
Gross Profit 11.72% -5.03% -4.82% 15.13% -38.70%
SG&A Expenses -27.23% -39.66% -54.84% -52.94% -39.76%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -22.92% -35.83% -47.54% -53.52% -31.44%
Operating Income 43.25% 48.77% 60.75% 63.78% 36.30%
Income Before Tax 55.40% 54.71% 17.71% 89.91% 71.86%
Income Tax Expenses 100.00% 275.00% 0.00% 155.36% 100.83%
Earnings from Continuing Operations 55.26% 54.34% 17.62% 89.69% 71.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 55.26% 54.34% 17.62% 89.69% 71.00%
EBIT 43.25% 48.77% 60.75% 63.78% 36.30%
EBITDA 42.48% 48.28% 60.52% 59.97% 29.46%
EPS Basic 94.77% 94.12% 94.00% -- --
Normalized Basic EPS 93.31% 92.65% 94.01% -- --
EPS Diluted 94.77% 94.12% 94.00% -- --
Normalized Diluted EPS 93.31% 92.65% 94.01% -- --
Average Basic Shares Outstanding 755.29% 676.61% 1,270.85% -- --
Average Diluted Shares Outstanding 755.29% 676.61% 1,270.85% -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings